Page 318 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 318

260.e6  Part III  Immunologic Basis of Hematology


        223.  Boon T, Coulie PG, Van den Eynde BJ, et al: Human T cell responses   229.  Ganss  R,  Ryschich  E,  Klar  E,  et al:  Combination  of  T-cell  therapy
            against  melanoma.  Annu  Rev  Immunol  24:175–208,  2006.  doi:   and trigger of inflammation induces remodeling of the vasculature and
            10.1146/annurev.immunol.24.021605.090733.             tumor eradication. Cancer Res 62:1462–1470, 2002.
        224.  Banchereau  J,  et al:  Immune  and  clinical  responses  in  patients  with   230.  Ganss  R,  Arnold  B,  Hammerling  GJ:  Mini-review:  overcoming
                                  +
            metastatic  melanoma  to  CD34   progenitor-derived  dendritic  cell   tumor-intrinsic resistance to immune effector function. Eur J Immunol
            vaccine. Cancer Res 61:6451–6458, 2001.               34:2635–2641, 2004. doi: 10.1002/eji.200425474.
                                                        +
        225.  Paczesny  S,  et al:  Expansion  of  melanoma-specific  cytolytic  CD8  T   231.  Reits EA, et al: Radiation modulates the peptide repertoire, enhances
            cell precursors in patients with metastatic melanoma vaccinated with   MHC class I expression, and induces successful antitumor immuno-
                +
            CD34  progenitor-derived dendritic cells. J Exp Med 199:1503–1511,   therapy. J Exp Med 203:1259–1271, 2006. doi: 10.1084/jem.20052494.
            2004. doi: 10.1084/jem.20032118.                  232.  Inoges S, et al: Clinical benefit associated with idiotypic vaccination in
        226.  Schuler-Thurner  B,  et al:  Rapid  induction  of  tumor-specific  type  1   patients with follicular lymphoma. J Natl Cancer Inst 98:1292–1301,
            T  helper  cells  in  metastatic  melanoma  patients  by  vaccination  with   2006. doi: 10.1093/jnci/djj358.
            mature,  cryopreserved,  peptide-loaded  monocyte-derived  dendritic   233.  Lu W, Arraes LC, Ferreira WT, et al: Therapeutic dendritic-cell vaccine
            cells. J Exp Med 195:1279–1288, 2002.                 for  chronic  HIV-1  infection.  Nat  Med  10:1359–1365,  2004.  doi:
        227.  Lou Y, et al: Dendritic cells strongly boost the antitumor activity of   10.1038/nm1147.
            adoptively transferred T cells in vivo. Cancer Res 64:6783–6790, 2004.
            doi: 10.1158/0008-5472.CAN-04-1621.
        228.  Rapoport AP, et al: Restoration of immunity in lymphopenic individu-
            als with cancer by vaccination and adoptive T-cell transfer. Nat Med
            11:1230–1237, 2005. doi: 10.1038/nm1310.
   313   314   315   316   317   318   319   320   321   322   323